Jim Cramer: Valeant Still Has $30 Billion in Debt, Despite Ackman Endorsement
Bill Ackman stands by Valeant Pharmaceuticals, but Jim Cramer says it's important to remember how much debt the company has.
Billionaire investor Bill Ackman still stands by the troubled Valeant Pharmaceuticals (VRX) , but TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said it's important to remember just how much debt the company has. 'They still have $30 billion in debt and I don't think the company's doing very well,' Cramer said.
At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.
